Skip to main content
Clinical Trials/TCTR20210326003
TCTR20210326003
Not Yet Recruiting
Phase 2

EFFECTIVENESS OF NEUROBIC EXERCISE PROGRAM ON MEMORY PERFORMANCE IN COMMUNITY-DWELLING OLDER ADULTS WITH MILD COGNITIVE IMPAIRMENT: A RANDOMIZED CONTROLLED CROSSOVER TRIA

BURAPHA UNIVERSITY0 sites32 target enrollmentMarch 26, 2021

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Many older people complain of impaired memory and do less well than the young in various cognitive tasks, particularly those relevant to memory. About one in ten people aged 65 years old has dementia, and the prevalence increases by age. The effects of mild cognitive impairment in older adults can negatively impact both the individuals themselves as well as the other people surrounding them.
Sponsor
BURAPHA UNIVERSITY
Enrollment
32
Status
Not Yet Recruiting
Last Updated
last year

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
March 26, 2021
End Date
December 30, 2021
Last Updated
last year
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Males and females aged 60 years or older who have MCI as screened by using the Montreal Cognitive Assessment (MoCA); persons with scores less than 24 are considered as having MCI.
  • 2\. Being independent as screened by using Modified Barthel ADL index (BAI); BAI score should be at least 12 which indicates independence.
  • 3\. Body Mass Index (BMI) score range 18\.49\-35\.00 kg/m2 According to Obesity Indices for Thais (Mookdadilok, 2012\), this value is used to indicate no malnutrition and obesity for Thai people.
  • 4\. No history of psychiatric disorder or neurological condition (e.g., epilepsy, stroke, dementia, head injury, depression, etc.)
  • 5\. No hearing or visual impairment as diagnosed by a physician.
  • 6\. Ability to write and read as well as communicate well.
  • 7\. Willingness to participate in the study throughout the program.

Exclusion Criteria

  • The participants who have severe complications or serious neurological or musculoskeletal conditions and serious conditions from comorbidity (e.g., diabetes mellitus, hypertension, stroke, cardiovascular disease, etc.), which make them unable to participate in the intervention, and older adults with a history of food or flower allergies that used in activities, will be excluded. Moreover, participants who do not participate in all sessions of intervention will also be excluded.

Outcomes

Primary Outcomes

Not specified

Similar Trials